BioSpace News Archive

Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of November 2019, representing $0.936 per Common Share on an annualized basis.

ALS Association Golden West Chapter Honors MTPA as a Champion in the Search for ALS Treatments

HealthLynked Corp. (OTCQB: HLYK), a provider of healthcare-related technology that connects doctors, patients and medical data, today reported its financial results for the three months ended September 30, 2019.

Epiphany Dermatology announced it has expanded its national presence into Montana through its partnership with Advanced Dermatology of Butte.

The U.S. Food and Drug Administration today cleared for marketing in the U.S. the first duodenoscope with a sterile, disposable elevator component that will reduce the number of parts that need to be cleaned and disinfected (reprocessed) in between uses.

Today, the U.S. Food and Drug Administration approved Adakveo (crizanlizumab-tmca), a treatment to reduce the frequency of vaso-occlusive crisis – a common and painful complication of sickle cell disease that occurs when blood circulation is obstructed by sickled red blood cells – for patients age 16 years and older.

RemeGen, Ltd. today announced a Phase IIb clinical trial of RC18 (telitacicept), a potential new medicine for the treatment of systemic lupus erythematosus (SLE), met its primary endpoint of a greater than 4-point reduction in the SLE Responder Index (SRI4).

In a test to improve delivery of health services between communities in the U.S. Virgin Islands (USVI) and its public health laboratory, the USVI Department of Health, Association of Public Health Laboratories (APHL) and other collaborators made a successful 43-mile open-ocean drone crossing last week between St. Croix and St. Thomas.

Novartis announced today that the US Food and Drug Administration (FDA) approved Adakveo® (crizanlizumab-tmca), previously known as SEG101, to reduce the frequency of vaso-occlusive crises (VOCs), or pain crises, in adult and pediatric patients aged 16 years and older with sickle cell disease

“Based on our traceback investigation of recent cases of Scombrotoxin fish poisoning, the FDA is warning all sectors of the supply chain to discard certain tuna supplied by Truong Phu Xanh Co., LTD of Vietnam and advising consumers not eat any of this product.